McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q1 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −31−100.0% | Sold out | Holders |
| Q3 2024 | 31 | $1.46K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 31 | $1.67K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 31 | $2.11K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 31 | $1.94K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 31 | $1.41K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 31 | $1.74K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 31 | $1.40K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 31 | $1.26K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 31 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 31 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 31 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 31 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 31 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 31 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 31 | $4.00K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.